FY2025 · ended Dec 31, 2025 · Revenue $947.71M, +36.3% YoY · Filed Feb 26, 2026
The Pennant Group, Inc. (PNTG) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $947.7 million and net income of $29.6 million. Free cash flow was $36.3 million. As of Sep 30, 2026 it held $18.4 million in cash and investments and $483.9 million in total debt.
Revenue (TTM)
$1.17B
+38.7% vs year-ago TTM
Net income (TTM)
$35.88M
+34.4% vs year-ago TTM
Operating cash flow (TTM)
$64.50M
+34.7% vs year-ago TTM
Free cash flow (TTM)
$34.35M
-4.9% vs year-ago TTM
EPS (TTM)
$1.00
+32.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
34.66M
+0.7% vs prior year
Net cash
$-465.54M
as of Sep 30, 2026
Operating margin
5.8%
FY 2026
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- PNTG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Eagle, ID
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1766400
Other Services-Health Services companies
- LifeStance Health Group, Inc. LFST
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- U S Physical Therapy Inc /NV USPH
- InnovAge Holding Corp. INNV
- Omada Health, Inc. OMDA
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $947.7M | $695.2M | $544.9M | $473.2M | $439.7M |
| Operating income | $51.9M | $38.1M | $25.2M | $12.7M | $4.7M |
| Net income | $29.6M | $22.6M | $13.4M | $6.6M | $2.7M |
| Diluted EPS | $0.84 | $0.70 | $0.44 | $0.22 | $0.09 |
| Operating cash flow | $48.3M | $39.3M | $33.1M | $9.0M | -$18.2M |
| Free cash flow | $36.3M | $30.3M | $25.0M | -$5.1M | -$24.5M |
| Total assets | $968.2M | $679.5M | $539.7M | $512.1M | $530.3M |
| Total liabilities | $593.9M | $367.6M | $394.2M | $386.5M | $416.1M |
| Stockholders' equity | $374.3M | $312.0M | $145.5M | $125.7M | $114.2M |
| Cash and investments | $17.0M | $24.2M | $6.1M | $2.1M | $5.2M |
| Total debt | $454.8M | $273.1M | $329.6M | $326.6M | $355.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
All 535 The Pennant Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.